{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:53:10Z","timestamp":1791582790965,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["25ZR1402327"],"award-info":[{"award-number":["25ZR1402327"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202540185"],"award-info":[{"award-number":["202540185"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YG2023ZD09"],"award-info":[{"award-number":["YG2023ZD09"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772362"],"award-info":[{"award-number":["2025M772362"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["No. 2024YFC3506104"],"award-info":[{"award-number":["No. 2024YFC3506104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502197"],"award-info":[{"award-number":["82502197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ard.2026.09.007","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:39Z","timestamp":1790109939000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiomics landscape of systemic sclerosis: from autoantibody-positivity to established disease"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6810-3538","authenticated-orcid":false,"given":"Fenglin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6185-6174","authenticated-orcid":false,"given":"Zhangyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2992-1456","authenticated-orcid":false,"given":"Wanyi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5487-9843","authenticated-orcid":false,"given":"Chenhan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6420-8134","authenticated-orcid":false,"given":"Zhe","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7379-645X","authenticated-orcid":false,"given":"Yuankai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1131-8441","authenticated-orcid":false,"given":"Chaoyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2767-2208","authenticated-orcid":false,"given":"Xuesong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-1660","authenticated-orcid":false,"given":"Aiting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1549-3499","authenticated-orcid":false,"given":"Xianting","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-3998","authenticated-orcid":false,"given":"Hanlin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-6038","authenticated-orcid":false,"given":"Liangjing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ard.2026.09.007_bib0001","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1016\/S2665-9913(23)00212-6","article-title":"Beyond very early systemic sclerosis: deciphering pre\u2011scleroderma and its trajectories to open new avenues for preventive medicine","volume":"5","author":"Lescoat","year":"2023","journal-title":"Lancet Rheumatol."},{"issue":"5","key":"10.1016\/j.ard.2026.09.007_bib0002","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ard.2025.11.021","article-title":"From the grey area of pre-systemic sclerosis to very early disease and irreversible tissue damage: the challenge of defining at-risk patients for future preventive trials in systemic sclerosis","volume":"85","author":"Lescoat","year":"2026","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.09.007_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00281-025-01065-6","article-title":"Systemic sclerosis: pathogenic mechanisms and their implications for treatment","volume":"47","author":"Lescoat","year":"2025","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.ard.2026.09.007_bib0004","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41584-021-00683-2","article-title":"Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential","volume":"17","author":"Tsou","year":"2021","journal-title":"Nat Rev Rheumatol."},{"issue":"10373","key":"10.1016\/j.ard.2026.09.007_bib0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ard.2026.09.007_bib0006","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"10.1016\/j.ard.2026.09.007_bib0007","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/rheumatology\/kep447","article-title":"Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy","volume":"49","author":"Ingegnoli","year":"2010","journal-title":"Rheumatology (Oxford)."},{"issue":"12","key":"10.1016\/j.ard.2026.09.007_bib0008","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.ard.2026.09.007_bib0009","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","article-title":"Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)","volume":"3","author":"Bellando-Randone","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"8","key":"10.1016\/j.ard.2026.09.007_bib0010","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.autrev.2017.05.013","article-title":"Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort","volume":"16","author":"Trapiella-Mart\u00ednez","year":"2017","journal-title":"Autoimmun Rev."},{"issue":"11","key":"10.1016\/j.ard.2026.09.007_bib0011","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ard.2026.09.007_bib0012","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.09.007_bib0013","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1093\/rheumatology\/keae698","article-title":"Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS)","volume":"64","author":"Ross","year":"2025","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"10.1016\/j.ard.2026.09.007_bib0014","doi-asserted-by":"crossref","first-page":"keaf457","DOI":"10.1093\/rheumatology\/keaf457","article-title":"Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry","volume":"65","author":"Bonomi","year":"2026","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"10.1016\/j.ard.2026.09.007_bib0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/rheumatology\/keq176","article-title":"Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features","volume":"50","author":"Valentini","year":"2011","journal-title":"Rheumatology (Oxford)."},{"issue":"3","key":"10.1016\/j.ard.2026.09.007_bib0016","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/biomedicines14030607","article-title":"Micro- and macro-vascular disease in systemic sclerosis and very early SSc (VEDOSS): results from a Monocentric Observational Study","volume":"14","author":"Zaccone","year":"2026","journal-title":"Biomedicines."},{"issue":"10","key":"10.1016\/j.ard.2026.09.007_bib0017","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care."},{"issue":"5","key":"10.1016\/j.ard.2026.09.007_bib0018","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ard.2026.09.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214202","article-title":"Autoantibodies are present before the clinical diagnosis of systemic sclerosis","volume":"14","author":"Burbelo","year":"2019","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.ard.2026.09.007_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12967-025-07469-0","article-title":"Systemic sclerosis: bridging clinical and molecular insights: results from the PRECISESADS study","volume":"24","author":"Dans-Caballero","year":"2025","journal-title":"J Transl Med."},{"key":"10.1016\/j.ard.2026.09.007_bib0021","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ard.2025.11.020","article-title":"Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multiomics analysis","volume":"85","author":"Lin","year":"2026","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.09.007_bib0022","doi-asserted-by":"crossref","first-page":"keaf634","DOI":"10.1093\/rheumatology\/keaf634","article-title":"Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC)","volume":"65","author":"Jia","year":"2026","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ard.2026.09.007_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152810","article-title":"Dual positivity for Anti-Ro52 and Anti-Ro60 antibodies is linked to greater organ involvement and disease progression in systemic sclerosis","volume":"74","author":"Yin","year":"2025","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ard.2026.09.007_bib0024","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ard.2026.09.007_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/RHU.0000000000000971","article-title":"Performance of anti-topoisomerase I antibody testing by multiple-bead, ELISA and immunodiffusion in a university setting","volume":"26","author":"Homer","year":"2020","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.ard.2026.09.007_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152052","article-title":"False positive anti-topoisomerase I (Scl-70) antibody results in clinical practice: a case series from a scleroderma referral center","volume":"56","author":"Lam","year":"2022","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ard.2026.09.007_bib0027","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol."},{"key":"10.1016\/j.ard.2026.09.007_bib0028","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1515\/cclm-2018-0188","article-title":"International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I","volume":"56","author":"Andrade","year":"2018","journal-title":"Clin Chem Lab Med."},{"issue":"12","key":"10.1016\/j.ard.2026.09.007_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.ard.2026.09.007_bib55","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.ard.2026.09.007_bib56","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.ard.2026.09.007_bib0029","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2105-7-191","article-title":"STEM: a tool for the analysis of short time series gene expression data","volume":"7","author":"Ernst","year":"2006","journal-title":"BMC Bioinformatics."},{"issue":"6","key":"10.1016\/j.ard.2026.09.007_bib0030","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.ard.2026.09.007_bib0031","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ard.2025.10.033","article-title":"RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis","volume":"85","author":"Parvizi","year":"2026","journal-title":"Ann Rheum Dis."},{"issue":"7","key":"10.1016\/j.ard.2026.09.007_bib0032","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard.2010.134742","article-title":"Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis","volume":"70","author":"Dees","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.09.007_bib0033","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00011-025-02126-0","article-title":"Systemic sclerosis, main culprits and involved signaling pathways","volume":"74","author":"Sadatpour","year":"2025","journal-title":"Inflamm Res."},{"issue":"6","key":"10.1016\/j.ard.2026.09.007_bib0034","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/S2665-9913(24)00403-X","article-title":"Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study","volume":"7","author":"Hinchcliff","year":"2025","journal-title":"Lancet Rheumatol."},{"issue":"4","key":"10.1016\/j.ard.2026.09.007_bib0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","article-title":"Type I interferon in rheumatic diseases","volume":"14","author":"Muskardin","year":"2018","journal-title":"Nat Rev Rheumatol."},{"issue":"4","key":"10.1016\/j.ard.2026.09.007_bib0036","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/rheumatology\/keac492","article-title":"Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression","volume":"62","author":"Bellocchi","year":"2023","journal-title":"Rheumatology (Oxford)."},{"issue":"SI","key":"10.1016\/j.ard.2026.09.007_bib0037","doi-asserted-by":"crossref","first-page":"SI12","DOI":"10.1093\/rheumatology\/keac421","article-title":"Toll-like receptor triggering in systemic sclerosis: time to target","volume":"62","author":"O\u2019Reilly","year":"2023","journal-title":"Rheumatology (Oxford)."},{"issue":"12","key":"10.1016\/j.ard.2026.09.007_bib0038","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat Immunol."},{"issue":"1","key":"10.1016\/j.ard.2026.09.007_bib0039","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.42662","article-title":"Endothelial response to Type I interferon contributes to vasculopathy and fibrosis and predicts disease progression of systemic sclerosis","volume":"76","author":"Yin","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ard.2026.09.007_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jdermsci.2025.01.002","article-title":"Aberrant fumarate metabolism links interferon release in diffuse systemic sclerosis","volume":"117","author":"Steadman","year":"2025","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ard.2026.09.007_bib0041","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s11658-017-0035-3","article-title":"The regulatory mechanisms of NG2\/CSPG4 expression","volume":"22","author":"Ampofo","year":"2017","journal-title":"Cell Mol Biol Lett."},{"issue":"6","key":"10.1016\/j.ard.2026.09.007_bib0042","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3390\/ijms26062421","article-title":"The role of CXCL4 in systemic sclerosis: DAMP, auto-antigen and biomarker","volume":"26","author":"Porreca","year":"2025","journal-title":"Int J Mol Sci."},{"issue":"14","key":"10.1016\/j.ard.2026.09.007_bib0043","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.3390\/ijms21145102","article-title":"Anti-CXCL4 antibody reactivity is present in systemic sclerosis (SSc) and correlates with the SSc Type I interferon signature","volume":"21","author":"Lande","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"Suppl 1","key":"10.1016\/j.ard.2026.09.007_bib0044","first-page":"A34","article-title":"OC.35 Platelets\u2019 metabolism and functions in very early diagnosis of systemic sclerosis and in established disease","volume":"11","author":"Villa","year":"2026","journal-title":"J Scleroderma Relat Disord."},{"issue":"7","key":"10.1016\/j.ard.2026.09.007_bib0045","article-title":"Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity","volume":"4","author":"Nakayasu","year":"2023","journal-title":"Cell Rep Med."},{"issue":"9","key":"10.1016\/j.ard.2026.09.007_bib0046","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/art.43175","article-title":"Serum proteomic signatures before the diagnosis of rheumatoid arthritis: evolving biologic pathways and specific periods of disease development","volume":"77","author":"Rachid Zaim","year":"2025","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.09.007_bib0047","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.41483","article-title":"Association of a serum protein signature with rheumatoid arthritis development","volume":"73","author":"O'Neil","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"10429","key":"10.1016\/j.ard.2026.09.007_bib0048","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(23)02649-1","article-title":"Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial","volume":"403","author":"Cope","year":"2024","journal-title":"Lancet."},{"issue":"10","key":"10.1016\/j.ard.2026.09.007_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103168","article-title":"JAK inhibitors and systemic sclerosis: a systematic review of the literature","volume":"21","author":"Moriana","year":"2022","journal-title":"Autoimmun Rev."},{"issue":"11","key":"10.1016\/j.ard.2026.09.007_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11926-020-00953-0","article-title":"Understanding fibrosis in systemic sclerosis: novel and emerging treatment approaches","volume":"22","author":"Yin","year":"2020","journal-title":"Curr Rheumatol Rep."},{"issue":"2","key":"10.1016\/j.ard.2026.09.007_bib0051","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2026-006716","article-title":"Scoping literature review on applied definitions of very early diagnosis of systemic sclerosis (VEDOSS) and pre-systemic sclerosis in original articles","volume":"12","author":"Lescoat","year":"2026","journal-title":"RMD Open."},{"key":"10.1016\/j.ard.2026.09.007_bib0052","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.autrev.2009.02.002","article-title":"Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression","volume":"8","author":"Cavazzana","year":"2009","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.ard.2026.09.007_bib0053","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10067-019-04806-9","article-title":"Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients","volume":"39","author":"Liu","year":"2020","journal-title":"Clin Rheumatol."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726005583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726005583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:09:56Z","timestamp":1791580196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726005583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"alternative-id":["S0003496726005583"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.09.007","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiomics landscape of systemic sclerosis: from autoantibody-positivity to established disease","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}